Rodger D. MacArthur

Treatment with Lamivudine, Zidovudine, or Both in HIV-Positive Patients with 200 to 500 CD4+ Cells per Cubic Millimeter

Joseph J. Eron, Sharon L. Benoit, Joseph G. Jemsek et al. · New England Journal of Medicine · 1995 · 538 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Low-Abundance Drug-Resistant Viral Variants in Chronically HIV-Infected, Antiretroviral Treatment–Naive Patients Significantly Impact Treatment Outcomes

Birgitte B. Simen, Jan Fredrik Simons, Katherine Huppler Hullsiek et al. · The Journal of Infectious Diseases · 2009 · 394 citations

Life Sciences, Infectious Diseases, Molecular Virology +16

Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F(ab′)2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels*

Edward A. Panacek, John C. Marshall, Timothy E. Albertson et al. · Critical Care Medicine · 2004 · 384 citations

Veterinary Medicine, Immunology, Pharmacotherapy +16

CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infection

Jason V. Baker, Grace Peng, Joshua Rapkin et al. · AIDS · 2008 · 371 citations · Full text

Public Health, Health Sciences, Infectious Diseases +12

Adequacy of Early Empiric Antibiotic Treatment and Survival in Severe Sepsis: Experience from the MONARCS Trial

Rodger D. MacArthur, Mark Miller, Timothy Albertson et al. · Clinical Infectious Diseases · 2004 · 273 citations

Veterinary Medicine, Infectious Diseases, Pharmacotherapy +16